TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat

Peptides
C PetrellaG Improta

Abstract

The aims of this paper were to study: (1) the effects of TLQP-21 (non-acronic name), the C-terminal region of the VGF (non-acronic name), polypeptide (from residue 557 to 576 of VGF), on in vitro amylase release from rat isolated pancreatic lobules and acinar cells; (2) the mechanism through which TLQP-21 regulates exocrine pancreatic secretion, by using the muscarinic receptor antagonist atropine (10(-6)M) and the cyclo-oxygenase inhibitor, indomethacin (10(-6)M). On pancreatic lobules of rats, concentrations of TLQP-21 from 10(-7) to 10(-5)M significantly (p<0.05) induced a 2-3-fold increase of baseline pancreatic amylase release, measured at the end of 60 min incubation period. Co-incubation with atropine 10(-6)M did not antagonise the enzyme outflow induced by the peptide. On the contrary, co-incubation of TLQP-21 (10(-7) and 10(-6)M) with indomethacin, at concentration of 10(-6)M, which alone did not modify enzyme secretion, completely suppressed the increase of amylase evoked by TLQP-21 on pancreatic lobules. On rat pancreatic acinar cells, TLQP-21, at all the concentrations tested, was unable to affect exocrine pancreatic secretion, indicating an indirect mechanism of action on acinar cells. These results put in evidence...Continue Reading

References

Jan 1, 1977·The American Journal of Digestive Diseases·S J KonturekJ Oleksy
Dec 1, 1969·Clinica Chimica Acta; International Journal of Clinical Chemistry·M CeskaK Birath
Sep 21, 2000·The Proceedings of the Nutrition Society·G A Bray
Aug 24, 2002·Pflügers Archiv : European journal of physiology·Ji Eun LeeSung Joon Kim
Jul 6, 2004·Cellular and Molecular Neurobiology·Andrea LeviStephen R J Salton
Sep 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·A BartolomucciA Moles
Feb 22, 2007·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Cristina CoccoGian-Luca Ferri
Apr 28, 2007·Regulatory Peptides·Katarzyna Nawrot-PorabkaWiesław W Pawlik
Sep 29, 2007·European Journal of Pharmacology·María E SabbatiniLiliana G Bianciotti
Oct 14, 2008·Genes & Nutrition·Alessandro BartolomucciAnna Moles
Oct 25, 2008·Cell Biology International·Manfred V Singer, Elke Niebergall-Roth
Dec 17, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G LinariM Broccardo
Jun 19, 2009·Current Opinion in Gastroenterology·Rashmi Chandra, Rodger A Liddle
Aug 25, 2011·Endocrine Reviews·Alessandro BartolomucciStephen R J Salton

❮ Previous
Next ❯

Citations

Jul 3, 2013·Current Opinion in Gastroenterology·Rashmi Chandra, Rodger A Liddle
Aug 14, 2013·The Journal of Biological Chemistry·Sebastien HannedoucheFrederic Bassilana
Dec 28, 2019·International Journal of Molecular Sciences·Elena BrescianiAntonio Torsello
Jul 1, 2018·Neuropeptides·ZengKui GuoAlessandro Bartolomucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.